Sean Sheridan, Principal, Charles River Associates to Speak at The Knowledge Group’s Event
The Knowledge Group, the leading producer of regulatory focused webcasts, has announced today that Sean Sheridan, Principal, Charles River Associates will speak at its webcast entitled, “What’s New for Hatch-Waxman Litigation: Exploring Trends, Updates, and Critical Issues LIVE Webcast.”
- (1888PressRelease) May 11, 2022 - This event is scheduled for Tuesday, May 17, 2022 from 3:00 pm to 5:00 pm (ET).
For further details, please visit: https://knowledgewebcasts.com/know-portfolio/hatch-waxman-litigation-cle/
About Sean Sheridan
Dr. Sean Sheridan is a principal in the Life Sciences Practice at CRA. He has served as an expert witness in cases brought before federal and state courts, the Patent Trial and Appeal Board, the International Trade Commission, and arbitration tribunals.
Dr. Sheridan has developed numerous damages analyses related to patent infringement, breach of contract, and trade secret misappropriation, including analyses quantifying lost profits, reasonable royalties, and unjust enrichment. He has also provided financial consulting services for a variety of non-litigation purposes including transaction due diligence, license negotiations, and strategic decision‐making. The engagements he has worked on span a wide range of industries and products, including pharmaceuticals, recombinant therapeutic proteins, vaccines, gene editing, medical devices, diagnostics, research tools, electronic health records, and many others outside of the life sciences.
About Charles River Associates
Charles River Associates (CRA) is a leading global consulting firm that offers economic, financial, and strategic expertise to major law firms, corporations, accounting firms, and governments around the world. Our experts bring a unique combination of cutting-edge research, state-of-the-art methods, and proven experience to bear on our clients’ most complex challenges.
CRA specializes in management consulting and economic litigation. Our senior-led teams include leading academic experts and business leaders with experience across industries. Because of our proven skills in complex cases and exceptional strength in analytics, clients depend on our objective, fact-based advice for their high-profile, high-stakes matters.
Event Summary
As the COVID-19 crisis stretches into its third year, brands and generic drug companies will likely see the impact of continued regulatory developments in the Hatch-Waxman space.
Moreover, recent notable cases further reveal key takeaways and unresolved issues which drug companies should be wary of. Among the salient developments involve changes in venue for a Hatch-Waxman Act case — highlighting the need for concerned practitioners to stay close to the venue issue as it remains to be a focus of the Federal courts.
In this LIVE Webcast, a panel of key thought leaders and practitioners will offer an in-depth look at the critical developments and issues surrounding Hatch-Waxman litigation. This interactive course will provide helpful insights to help your company deal with patent challenges.
Key topics include:
• Hatch-Waxman Litigation Post-COVID
• Impact of Changes in Venue for Hatch-Waxman Litigation
• Regulatory and Litigation Impact of Carve-Outs
• Economic Issues Associated With an “at-risk” Launch
• Factors to Consider When Analyzing Commercial Success
• Recent Notable Cases
About The Knowledge Group
Founded in November 2006, The Knowledge Group has been at the forefront of providing quality continuing education programs for lawyers, accountants, financial executives, risk and compliance specialists, human resources professionals, technology officers, and business consultants in a wide range of industries.
The Knowledge Group strives to be the best-in-class provider of continuing education by bringing forth relevant content you can’t get anywhere else.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam